nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—thyroid cancer—head and neck cancer	0.13	0.24	CtDrD
Doxorubicin—bone cancer—head and neck cancer	0.0967	0.178	CtDrD
Doxorubicin—stomach cancer—head and neck cancer	0.0916	0.169	CtDrD
Doxorubicin—muscle cancer—head and neck cancer	0.0854	0.157	CtDrD
Doxorubicin—peripheral nervous system neoplasm—head and neck cancer	0.0708	0.13	CtDrD
Doxorubicin—sarcoma—head and neck cancer	0.0681	0.125	CtDrD
Doxorubicin—ABCC6—Vinblastine—head and neck cancer	0.0581	0.214	CbGbCtD
Doxorubicin—ABCC10—Docetaxel—head and neck cancer	0.0366	0.134	CbGbCtD
Doxorubicin—ABCC3—Fluorouracil—head and neck cancer	0.0301	0.111	CbGbCtD
Doxorubicin—ABCB11—Vinblastine—head and neck cancer	0.0241	0.0887	CbGbCtD
Doxorubicin—CYP1B1—Docetaxel—head and neck cancer	0.0199	0.0731	CbGbCtD
Doxorubicin—ABCC1—Vinblastine—head and neck cancer	0.0171	0.063	CbGbCtD
Doxorubicin—ABCC1—Docetaxel—head and neck cancer	0.0141	0.0519	CbGbCtD
Doxorubicin—ABCC2—Vinblastine—head and neck cancer	0.0127	0.0466	CbGbCtD
Doxorubicin—ABCG2—Fluorouracil—head and neck cancer	0.0124	0.0455	CbGbCtD
Doxorubicin—CYP2D6—Hydroxyurea—head and neck cancer	0.011	0.0405	CbGbCtD
Doxorubicin—ABCC2—Docetaxel—head and neck cancer	0.0105	0.0384	CbGbCtD
Doxorubicin—ABCG2—Docetaxel—head and neck cancer	0.00946	0.0347	CbGbCtD
Doxorubicin—ABCB1—Vinblastine—head and neck cancer	0.00414	0.0152	CbGbCtD
Doxorubicin—CYP2D6—Vinblastine—head and neck cancer	0.0039	0.0143	CbGbCtD
Doxorubicin—ABCB1—Docetaxel—head and neck cancer	0.00341	0.0125	CbGbCtD
Doxorubicin—CYP3A4—Vinblastine—head and neck cancer	0.00248	0.00911	CbGbCtD
Doxorubicin—CYP3A4—Docetaxel—head and neck cancer	0.00204	0.00751	CbGbCtD
Doxorubicin—ABCB8—tongue—head and neck cancer	0.00165	0.0392	CbGeAlD
Doxorubicin—CBR3—hair follicle—head and neck cancer	0.00136	0.0323	CbGeAlD
Doxorubicin—ABCB8—mouth—head and neck cancer	0.00111	0.0264	CbGeAlD
Doxorubicin—AKR1A1—hair follicle—head and neck cancer	0.00105	0.025	CbGeAlD
Doxorubicin—NDUFS2—hair follicle—head and neck cancer	0.000791	0.0188	CbGeAlD
Doxorubicin—NDUFS3—hair follicle—head and neck cancer	0.000781	0.0186	CbGeAlD
Doxorubicin—NDUFS7—mouth—head and neck cancer	0.000749	0.0178	CbGeAlD
Doxorubicin—CBR3—parotid gland—head and neck cancer	0.000743	0.0177	CbGeAlD
Doxorubicin—DHCR7—hair follicle—head and neck cancer	0.000742	0.0176	CbGeAlD
Doxorubicin—CBR3—saliva-secreting gland—head and neck cancer	0.000712	0.0169	CbGeAlD
Doxorubicin—RALBP1—hair follicle—head and neck cancer	0.000615	0.0146	CbGeAlD
Doxorubicin—NDUFS3—mouth—head and neck cancer	0.000613	0.0146	CbGeAlD
Doxorubicin—NQO1—Vincristine—Vinblastine—head and neck cancer	0.000587	0.296	CbGdCrCtD
Doxorubicin—AKR1A1—parotid gland—head and neck cancer	0.000574	0.0136	CbGeAlD
Doxorubicin—AKR1A1—saliva-secreting gland—head and neck cancer	0.00055	0.0131	CbGeAlD
Doxorubicin—CBR3—trachea—head and neck cancer	0.000549	0.013	CbGeAlD
Doxorubicin—AKR1C3—Vincristine—Vinblastine—head and neck cancer	0.000469	0.237	CbGdCrCtD
Doxorubicin—NDUFS7—connective tissue—head and neck cancer	0.000459	0.0109	CbGeAlD
Doxorubicin—ABCB8—thyroid gland—head and neck cancer	0.000451	0.0107	CbGeAlD
Doxorubicin—CBR3—thyroid gland—head and neck cancer	0.000434	0.0103	CbGeAlD
Doxorubicin—NDUFS2—parotid gland—head and neck cancer	0.000432	0.0103	CbGeAlD
Doxorubicin—NDUFS3—parotid gland—head and neck cancer	0.000427	0.0101	CbGeAlD
Doxorubicin—AKR1A1—trachea—head and neck cancer	0.000424	0.0101	CbGeAlD
Doxorubicin—NDUFS2—saliva-secreting gland—head and neck cancer	0.000414	0.00984	CbGeAlD
Doxorubicin—NDUFS3—saliva-secreting gland—head and neck cancer	0.000409	0.00972	CbGeAlD
Doxorubicin—NOS3—neck—head and neck cancer	0.000406	0.00965	CbGeAlD
Doxorubicin—DHCR7—parotid gland—head and neck cancer	0.000406	0.00964	CbGeAlD
Doxorubicin—ABCB8—head—head and neck cancer	0.0004	0.00951	CbGeAlD
Doxorubicin—DHCR7—saliva-secreting gland—head and neck cancer	0.000389	0.00923	CbGeAlD
Doxorubicin—CBR3—head—head and neck cancer	0.000385	0.00916	CbGeAlD
Doxorubicin—NDUFS2—connective tissue—head and neck cancer	0.00038	0.00904	CbGeAlD
Doxorubicin—NDUFS3—connective tissue—head and neck cancer	0.000376	0.00893	CbGeAlD
Doxorubicin—YWHAG—parotid gland—head and neck cancer	0.000372	0.00884	CbGeAlD
Doxorubicin—AKR1A1—lymphoid tissue—head and neck cancer	0.000369	0.00877	CbGeAlD
Doxorubicin—NOS1—epithelium—head and neck cancer	0.000363	0.00863	CbGeAlD
Doxorubicin—Daunorubicin—CYP1A1—head and neck cancer	0.000363	1	CrCbGaD
Doxorubicin—NQO1—mouth—head and neck cancer	0.000361	0.00858	CbGeAlD
Doxorubicin—CBR1—Vincristine—Vinblastine—head and neck cancer	0.000358	0.181	CbGdCrCtD
Doxorubicin—YWHAG—saliva-secreting gland—head and neck cancer	0.000357	0.00847	CbGeAlD
Doxorubicin—ABCC6—connective tissue—head and neck cancer	0.000348	0.00827	CbGeAlD
Doxorubicin—RALBP1—parotid gland—head and neck cancer	0.000336	0.00799	CbGeAlD
Doxorubicin—AKR1A1—thyroid gland—head and neck cancer	0.000335	0.00797	CbGeAlD
Doxorubicin—YWHAG—connective tissue—head and neck cancer	0.000328	0.00778	CbGeAlD
Doxorubicin—CYP1B1—hair follicle—head and neck cancer	0.000323	0.00768	CbGeAlD
Doxorubicin—RALBP1—saliva-secreting gland—head and neck cancer	0.000322	0.00765	CbGeAlD
Doxorubicin—NDUFS2—trachea—head and neck cancer	0.000319	0.00759	CbGeAlD
Doxorubicin—NDUFS3—trachea—head and neck cancer	0.000315	0.00749	CbGeAlD
Doxorubicin—CBR1—parotid gland—head and neck cancer	0.000314	0.00746	CbGeAlD
Doxorubicin—AURKA—lymphoid tissue—head and neck cancer	0.000312	0.00741	CbGeAlD
Doxorubicin—AKR1C3—parotid gland—head and neck cancer	0.00031	0.00736	CbGeAlD
Doxorubicin—NQO1—neck—head and neck cancer	0.000309	0.00733	CbGeAlD
Doxorubicin—NDUFS7—thyroid gland—head and neck cancer	0.000305	0.00724	CbGeAlD
Doxorubicin—CBR1—saliva-secreting gland—head and neck cancer	0.000301	0.00714	CbGeAlD
Doxorubicin—DHCR7—trachea—head and neck cancer	0.0003	0.00712	CbGeAlD
Doxorubicin—AKR1A1—head—head and neck cancer	0.000298	0.00707	CbGeAlD
Doxorubicin—NOS3—connective tissue—head and neck cancer	0.000291	0.00691	CbGeAlD
Doxorubicin—ABCC1—hair follicle—head and neck cancer	0.000291	0.00691	CbGeAlD
Doxorubicin—AURKA—thyroid gland—head and neck cancer	0.000283	0.00673	CbGeAlD
Doxorubicin—POR—parotid gland—head and neck cancer	0.000283	0.00672	CbGeAlD
Doxorubicin—ABCB8—lymph node—head and neck cancer	0.00028	0.00666	CbGeAlD
Doxorubicin—NDUFS2—lymphoid tissue—head and neck cancer	0.000278	0.00661	CbGeAlD
Doxorubicin—NOS3—epithelium—head and neck cancer	0.000276	0.00656	CbGeAlD
Doxorubicin—YWHAG—trachea—head and neck cancer	0.000275	0.00653	CbGeAlD
Doxorubicin—NDUFS3—lymphoid tissue—head and neck cancer	0.000275	0.00653	CbGeAlD
Doxorubicin—POR—saliva-secreting gland—head and neck cancer	0.000271	0.00644	CbGeAlD
Doxorubicin—NDUFS7—head—head and neck cancer	0.00027	0.00643	CbGeAlD
Doxorubicin—CBR3—lymph node—head and neck cancer	0.00027	0.00641	CbGeAlD
Doxorubicin—DHCR7—lymphoid tissue—head and neck cancer	0.000261	0.0062	CbGeAlD
Doxorubicin—NOS1—thyroid gland—head and neck cancer	0.000254	0.00604	CbGeAlD
Doxorubicin—NDUFS2—thyroid gland—head and neck cancer	0.000253	0.006	CbGeAlD
Doxorubicin—AURKA—head—head and neck cancer	0.000251	0.00597	CbGeAlD
Doxorubicin—NQO1—parotid gland—head and neck cancer	0.000251	0.00597	CbGeAlD
Doxorubicin—NDUFS3—thyroid gland—head and neck cancer	0.00025	0.00593	CbGeAlD
Doxorubicin—RALBP1—trachea—head and neck cancer	0.000248	0.0059	CbGeAlD
Doxorubicin—NOS3—trachea—head and neck cancer	0.000244	0.0058	CbGeAlD
Doxorubicin—NQO1—saliva-secreting gland—head and neck cancer	0.000241	0.00572	CbGeAlD
Doxorubicin—YWHAG—lymphoid tissue—head and neck cancer	0.00024	0.00569	CbGeAlD
Doxorubicin—DHCR7—thyroid gland—head and neck cancer	0.000237	0.00563	CbGeAlD
Doxorubicin—CBR1—trachea—head and neck cancer	0.000232	0.00551	CbGeAlD
Doxorubicin—ABCC6—thyroid gland—head and neck cancer	0.000231	0.00549	CbGeAlD
Doxorubicin—AKR1C3—trachea—head and neck cancer	0.000229	0.00544	CbGeAlD
Doxorubicin—NOS1—head—head and neck cancer	0.000226	0.00536	CbGeAlD
Doxorubicin—ABCC10—parotid gland—head and neck cancer	0.000225	0.00533	CbGeAlD
Doxorubicin—NDUFS2—head—head and neck cancer	0.000224	0.00532	CbGeAlD
Doxorubicin—NDUFS3—head—head and neck cancer	0.000221	0.00526	CbGeAlD
Doxorubicin—NQO1—connective tissue—head and neck cancer	0.000221	0.00526	CbGeAlD
Doxorubicin—YWHAG—thyroid gland—head and neck cancer	0.000218	0.00517	CbGeAlD
Doxorubicin—ABCC10—saliva-secreting gland—head and neck cancer	0.000215	0.00511	CbGeAlD
Doxorubicin—NOS3—lymphoid tissue—head and neck cancer	0.000213	0.00506	CbGeAlD
Doxorubicin—DHCR7—head—head and neck cancer	0.00021	0.005	CbGeAlD
Doxorubicin—NQO1—epithelium—head and neck cancer	0.00021	0.00499	CbGeAlD
Doxorubicin—POR—trachea—head and neck cancer	0.000209	0.00497	CbGeAlD
Doxorubicin—AKR1A1—lymph node—head and neck cancer	0.000208	0.00495	CbGeAlD
Doxorubicin—ABCC6—head—head and neck cancer	0.000205	0.00487	CbGeAlD
Doxorubicin—CBR1—lymphoid tissue—head and neck cancer	0.000202	0.0048	CbGeAlD
Doxorubicin—RALBP1—thyroid gland—head and neck cancer	0.000196	0.00467	CbGeAlD
Doxorubicin—NOS3—thyroid gland—head and neck cancer	0.000193	0.00459	CbGeAlD
Doxorubicin—YWHAG—head—head and neck cancer	0.000193	0.00459	CbGeAlD
Doxorubicin—NDUFS7—lymph node—head and neck cancer	0.000189	0.0045	CbGeAlD
Doxorubicin—NQO1—trachea—head and neck cancer	0.000186	0.00441	CbGeAlD
Doxorubicin—CBR1—thyroid gland—head and neck cancer	0.000183	0.00436	CbGeAlD
Doxorubicin—AKR1C3—thyroid gland—head and neck cancer	0.000181	0.0043	CbGeAlD
Doxorubicin—TOP2A—Vindesine—Vinblastine—head and neck cancer	0.00018	0.0909	CbGdCrCtD
Doxorubicin—TOP2A—Paclitaxel—Docetaxel—head and neck cancer	0.000177	0.0893	CbGdCrCtD
Doxorubicin—AURKA—lymph node—head and neck cancer	0.000176	0.00418	CbGeAlD
Doxorubicin—RALBP1—head—head and neck cancer	0.000174	0.00414	CbGeAlD
Doxorubicin—NOS3—head—head and neck cancer	0.000171	0.00407	CbGeAlD
Doxorubicin—ABCC10—trachea—head and neck cancer	0.000166	0.00394	CbGeAlD
Doxorubicin—POR—thyroid gland—head and neck cancer	0.000165	0.00393	CbGeAlD
Doxorubicin—CBR1—head—head and neck cancer	0.000163	0.00387	CbGeAlD
Doxorubicin—ABCC1—parotid gland—head and neck cancer	0.000159	0.00377	CbGeAlD
Doxorubicin—NDUFS2—lymph node—head and neck cancer	0.000157	0.00373	CbGeAlD
Doxorubicin—CYP1B1—connective tissue—head and neck cancer	0.000155	0.00369	CbGeAlD
Doxorubicin—NDUFS3—lymph node—head and neck cancer	0.000155	0.00368	CbGeAlD
Doxorubicin—TOP2A—thyroid gland—head and neck cancer	0.000154	0.00366	CbGeAlD
Doxorubicin—DHCR7—lymph node—head and neck cancer	0.000147	0.0035	CbGeAlD
Doxorubicin—NQO1—thyroid gland—head and neck cancer	0.000147	0.00349	CbGeAlD
Doxorubicin—ABCC10—lymphoid tissue—head and neck cancer	0.000145	0.00343	CbGeAlD
Doxorubicin—YWHAG—lymph node—head and neck cancer	0.000135	0.00321	CbGeAlD
Doxorubicin—ABCC3—thyroid gland—head and neck cancer	0.000132	0.00313	CbGeAlD
Doxorubicin—ABCG2—parotid gland—head and neck cancer	0.000131	0.00312	CbGeAlD
Doxorubicin—ABCC10—thyroid gland—head and neck cancer	0.000131	0.00312	CbGeAlD
Doxorubicin—NQO1—head—head and neck cancer	0.00013	0.0031	CbGeAlD
Doxorubicin—ABCG2—saliva-secreting gland—head and neck cancer	0.000126	0.00299	CbGeAlD
Doxorubicin—RALBP1—lymph node—head and neck cancer	0.000122	0.0029	CbGeAlD
Doxorubicin—NOS3—lymph node—head and neck cancer	0.00012	0.00285	CbGeAlD
Doxorubicin—ABCC1—trachea—head and neck cancer	0.000117	0.00279	CbGeAlD
Doxorubicin—ABCC3—head—head and neck cancer	0.000117	0.00278	CbGeAlD
Doxorubicin—Neuropathy—Docetaxel—head and neck cancer	0.000116	0.00135	CcSEcCtD
Doxorubicin—Alopecia—Vinblastine—head and neck cancer	0.000115	0.00135	CcSEcCtD
Doxorubicin—CBR1—lymph node—head and neck cancer	0.000114	0.00271	CbGeAlD
Doxorubicin—TOP2A—Vinorelbine—Vinblastine—head and neck cancer	0.000114	0.0574	CbGdCrCtD
Doxorubicin—CYP1B1—lymphoid tissue—head and neck cancer	0.000114	0.0027	CbGeAlD
Doxorubicin—Dry skin—Fluorouracil—head and neck cancer	0.000114	0.00132	CcSEcCtD
Doxorubicin—AKR1C3—lymph node—head and neck cancer	0.000113	0.00267	CbGeAlD
Doxorubicin—Oesophagitis—Docetaxel—head and neck cancer	0.000113	0.00131	CcSEcCtD
Doxorubicin—Neoplasm—Docetaxel—head and neck cancer	0.000111	0.0013	CcSEcCtD
Doxorubicin—Nasopharyngitis—Fluorouracil—head and neck cancer	0.000111	0.00129	CcSEcCtD
Doxorubicin—Pulmonary oedema—Docetaxel—head and neck cancer	0.00011	0.00128	CcSEcCtD
Doxorubicin—Muscular weakness—Fluorouracil—head and neck cancer	0.000109	0.00127	CcSEcCtD
Doxorubicin—Angiopathy—Hydroxyurea—head and neck cancer	0.000108	0.00126	CcSEcCtD
Doxorubicin—Dysphagia—Fluorouracil—head and neck cancer	0.000107	0.00125	CcSEcCtD
Doxorubicin—Sepsis—Docetaxel—head and neck cancer	0.000107	0.00125	CcSEcCtD
Doxorubicin—Chills—Hydroxyurea—head and neck cancer	0.000107	0.00125	CcSEcCtD
Doxorubicin—Eosinophilia—Fluorouracil—head and neck cancer	0.000106	0.00124	CcSEcCtD
Doxorubicin—Ill-defined disorder—Vinblastine—head and neck cancer	0.000105	0.00123	CcSEcCtD
Doxorubicin—Alopecia—Hydroxyurea—head and neck cancer	0.000105	0.00123	CcSEcCtD
Doxorubicin—Anaemia—Vinblastine—head and neck cancer	0.000105	0.00123	CcSEcCtD
Doxorubicin—Angina pectoris—Fluorouracil—head and neck cancer	0.000104	0.00122	CcSEcCtD
Doxorubicin—Phlebitis—Docetaxel—head and neck cancer	0.000104	0.00121	CcSEcCtD
Doxorubicin—Erythema—Hydroxyurea—head and neck cancer	0.000104	0.00121	CcSEcCtD
Doxorubicin—Thrombophlebitis—Docetaxel—head and neck cancer	0.000103	0.0012	CcSEcCtD
Doxorubicin—CYP1B1—thyroid gland—head and neck cancer	0.000103	0.00245	CbGeAlD
Doxorubicin—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.000103	0.0012	CcSEcCtD
Doxorubicin—POR—lymph node—head and neck cancer	0.000103	0.00244	CbGeAlD
Doxorubicin—Malaise—Vinblastine—head and neck cancer	0.000102	0.0012	CcSEcCtD
Doxorubicin—Vertigo—Vinblastine—head and neck cancer	0.000102	0.00119	CcSEcCtD
Doxorubicin—Leukopenia—Vinblastine—head and neck cancer	0.000102	0.00119	CcSEcCtD
Doxorubicin—Pancytopenia—Fluorouracil—head and neck cancer	0.000102	0.00119	CcSEcCtD
Doxorubicin—Upper respiratory tract infection—Fluorouracil—head and neck cancer	9.95e-05	0.00116	CcSEcCtD
Doxorubicin—Hepatic failure—Docetaxel—head and neck cancer	9.95e-05	0.00116	CcSEcCtD
Doxorubicin—Cardiac failure congestive—Docetaxel—head and neck cancer	9.86e-05	0.00115	CcSEcCtD
Doxorubicin—Convulsion—Vinblastine—head and neck cancer	9.85e-05	0.00115	CcSEcCtD
Doxorubicin—Hypertension—Vinblastine—head and neck cancer	9.81e-05	0.00114	CcSEcCtD
Doxorubicin—Photosensitivity reaction—Fluorouracil—head and neck cancer	9.77e-05	0.00114	CcSEcCtD
Doxorubicin—TOP2A—Vincristine—Vinblastine—head and neck cancer	9.73e-05	0.0491	CbGdCrCtD
Doxorubicin—Ill-defined disorder—Hydroxyurea—head and neck cancer	9.61e-05	0.00112	CcSEcCtD
Doxorubicin—Pneumonia—Fluorouracil—head and neck cancer	9.6e-05	0.00112	CcSEcCtD
Doxorubicin—Anaemia—Hydroxyurea—head and neck cancer	9.58e-05	0.00112	CcSEcCtD
Doxorubicin—TOP2A—lymph node—head and neck cancer	9.58e-05	0.00228	CbGeAlD
Doxorubicin—Discomfort—Vinblastine—head and neck cancer	9.56e-05	0.00112	CcSEcCtD
Doxorubicin—Hot flush—Docetaxel—head and neck cancer	9.56e-05	0.00111	CcSEcCtD
Doxorubicin—Infestation NOS—Fluorouracil—head and neck cancer	9.54e-05	0.00111	CcSEcCtD
Doxorubicin—Infestation—Fluorouracil—head and neck cancer	9.54e-05	0.00111	CcSEcCtD
Doxorubicin—Menopausal symptoms—Docetaxel—head and neck cancer	9.47e-05	0.00111	CcSEcCtD
Doxorubicin—Renal impairment—Docetaxel—head and neck cancer	9.39e-05	0.0011	CcSEcCtD
Doxorubicin—Neuropathy peripheral—Fluorouracil—head and neck cancer	9.36e-05	0.00109	CcSEcCtD
Doxorubicin—Dermatitis bullous—Docetaxel—head and neck cancer	9.35e-05	0.00109	CcSEcCtD
Doxorubicin—Malaise—Hydroxyurea—head and neck cancer	9.34e-05	0.00109	CcSEcCtD
Doxorubicin—Stomatitis—Fluorouracil—head and neck cancer	9.3e-05	0.00109	CcSEcCtD
Doxorubicin—ABCC1—thyroid gland—head and neck cancer	9.28e-05	0.00221	CbGeAlD
Doxorubicin—Conjunctivitis—Fluorouracil—head and neck cancer	9.28e-05	0.00108	CcSEcCtD
Doxorubicin—Urinary tract infection—Fluorouracil—head and neck cancer	9.28e-05	0.00108	CcSEcCtD
Doxorubicin—Leukopenia—Hydroxyurea—head and neck cancer	9.28e-05	0.00108	CcSEcCtD
Doxorubicin—Cardiac failure—Docetaxel—head and neck cancer	9.16e-05	0.00107	CcSEcCtD
Doxorubicin—CYP1B1—head—head and neck cancer	9.16e-05	0.00218	CbGeAlD
Doxorubicin—NQO1—lymph node—head and neck cancer	9.13e-05	0.00217	CbGeAlD
Doxorubicin—Lethargy—Docetaxel—head and neck cancer	9.12e-05	0.00106	CcSEcCtD
Doxorubicin—Thrombocytopenia—Vinblastine—head and neck cancer	9.08e-05	0.00106	CcSEcCtD
Doxorubicin—Epistaxis—Fluorouracil—head and neck cancer	9e-05	0.00105	CcSEcCtD
Doxorubicin—Convulsion—Hydroxyurea—head and neck cancer	8.98e-05	0.00105	CcSEcCtD
Doxorubicin—Hyponatraemia—Docetaxel—head and neck cancer	8.98e-05	0.00105	CcSEcCtD
Doxorubicin—Sinusitis—Fluorouracil—head and neck cancer	8.95e-05	0.00104	CcSEcCtD
Doxorubicin—Pain in extremity—Docetaxel—head and neck cancer	8.94e-05	0.00104	CcSEcCtD
Doxorubicin—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	8.94e-05	0.00104	CcSEcCtD
Doxorubicin—Agranulocytosis—Fluorouracil—head and neck cancer	8.91e-05	0.00104	CcSEcCtD
Doxorubicin—Anorexia—Vinblastine—head and neck cancer	8.84e-05	0.00103	CcSEcCtD
Doxorubicin—Migraine—Docetaxel—head and neck cancer	8.8e-05	0.00103	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	8.76e-05	0.00102	CcSEcCtD
Doxorubicin—Discomfort—Hydroxyurea—head and neck cancer	8.72e-05	0.00102	CcSEcCtD
Doxorubicin—Haemoglobin—Fluorouracil—head and neck cancer	8.61e-05	0.001	CcSEcCtD
Doxorubicin—Rhinitis—Fluorouracil—head and neck cancer	8.59e-05	0.001	CcSEcCtD
Doxorubicin—Haemorrhage—Fluorouracil—head and neck cancer	8.57e-05	0.001	CcSEcCtD
Doxorubicin—Hypoaesthesia—Fluorouracil—head and neck cancer	8.53e-05	0.000995	CcSEcCtD
Doxorubicin—Pharyngitis—Fluorouracil—head and neck cancer	8.5e-05	0.000992	CcSEcCtD
Doxorubicin—Oedema—Hydroxyurea—head and neck cancer	8.46e-05	0.000987	CcSEcCtD
Doxorubicin—Ataxia—Docetaxel—head and neck cancer	8.41e-05	0.000981	CcSEcCtD
Doxorubicin—Infection—Hydroxyurea—head and neck cancer	8.4e-05	0.00098	CcSEcCtD
Doxorubicin—Paraesthesia—Vinblastine—head and neck cancer	8.33e-05	0.000972	CcSEcCtD
Doxorubicin—Dehydration—Docetaxel—head and neck cancer	8.31e-05	0.00097	CcSEcCtD
Doxorubicin—Nervous system disorder—Hydroxyurea—head and neck cancer	8.29e-05	0.000968	CcSEcCtD
Doxorubicin—Thrombocytopenia—Hydroxyurea—head and neck cancer	8.28e-05	0.000966	CcSEcCtD
Doxorubicin—Liver function test abnormal—Docetaxel—head and neck cancer	8.25e-05	0.000963	CcSEcCtD
Doxorubicin—Skin disorder—Hydroxyurea—head and neck cancer	8.21e-05	0.000958	CcSEcCtD
Doxorubicin—Dry skin—Docetaxel—head and neck cancer	8.19e-05	0.000956	CcSEcCtD
Doxorubicin—ABCC3—lymph node—head and neck cancer	8.19e-05	0.00195	CbGeAlD
Doxorubicin—Orthostatic hypotension—Docetaxel—head and neck cancer	8.16e-05	0.000953	CcSEcCtD
Doxorubicin—Abdominal pain upper—Docetaxel—head and neck cancer	8.16e-05	0.000953	CcSEcCtD
Doxorubicin—ABCC10—lymph node—head and neck cancer	8.15e-05	0.00194	CbGeAlD
Doxorubicin—Breast disorder—Docetaxel—head and neck cancer	8.08e-05	0.000942	CcSEcCtD
Doxorubicin—Anorexia—Hydroxyurea—head and neck cancer	8.06e-05	0.000941	CcSEcCtD
Doxorubicin—Decreased appetite—Vinblastine—head and neck cancer	8.06e-05	0.000941	CcSEcCtD
Doxorubicin—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	8.05e-05	0.000939	CcSEcCtD
Doxorubicin—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	8.05e-05	0.000939	CcSEcCtD
Doxorubicin—Nasopharyngitis—Docetaxel—head and neck cancer	7.99e-05	0.000933	CcSEcCtD
Doxorubicin—Constipation—Vinblastine—head and neck cancer	7.93e-05	0.000925	CcSEcCtD
Doxorubicin—Pain—Vinblastine—head and neck cancer	7.93e-05	0.000925	CcSEcCtD
Doxorubicin—Alanine aminotransferase increased—Docetaxel—head and neck cancer	7.88e-05	0.00092	CcSEcCtD
Doxorubicin—CYP2B6—lymphoid tissue—head and neck cancer	7.81e-05	0.00185	CbGeAlD
Doxorubicin—Dysphagia—Docetaxel—head and neck cancer	7.73e-05	0.000901	CcSEcCtD
Doxorubicin—ABCG2—thyroid gland—head and neck cancer	7.68e-05	0.00183	CbGeAlD
Doxorubicin—Arrhythmia—Fluorouracil—head and neck cancer	7.65e-05	0.000893	CcSEcCtD
Doxorubicin—Feeling abnormal—Vinblastine—head and neck cancer	7.64e-05	0.000892	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Vinblastine—head and neck cancer	7.58e-05	0.000885	CcSEcCtD
Doxorubicin—Alopecia—Fluorouracil—head and neck cancer	7.57e-05	0.000883	CcSEcCtD
Doxorubicin—Dyspnoea—Hydroxyurea—head and neck cancer	7.54e-05	0.00088	CcSEcCtD
Doxorubicin—Angina pectoris—Docetaxel—head and neck cancer	7.53e-05	0.000878	CcSEcCtD
Doxorubicin—Somnolence—Hydroxyurea—head and neck cancer	7.52e-05	0.000877	CcSEcCtD
Doxorubicin—Erythema—Fluorouracil—head and neck cancer	7.46e-05	0.00087	CcSEcCtD
Doxorubicin—Dyspepsia—Hydroxyurea—head and neck cancer	7.44e-05	0.000869	CcSEcCtD
Doxorubicin—Decreased appetite—Hydroxyurea—head and neck cancer	7.35e-05	0.000858	CcSEcCtD
Doxorubicin—Pancytopenia—Docetaxel—head and neck cancer	7.34e-05	0.000856	CcSEcCtD
Doxorubicin—Abdominal pain—Vinblastine—head and neck cancer	7.33e-05	0.000855	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	7.3e-05	0.000852	CcSEcCtD
Doxorubicin—Fatigue—Hydroxyurea—head and neck cancer	7.29e-05	0.000851	CcSEcCtD
Doxorubicin—Pain—Hydroxyurea—head and neck cancer	7.23e-05	0.000844	CcSEcCtD
Doxorubicin—Constipation—Hydroxyurea—head and neck cancer	7.23e-05	0.000844	CcSEcCtD
Doxorubicin—Neutropenia—Docetaxel—head and neck cancer	7.22e-05	0.000843	CcSEcCtD
Doxorubicin—Weight increased—Docetaxel—head and neck cancer	7.03e-05	0.00082	CcSEcCtD
Doxorubicin—Vision blurred—Fluorouracil—head and neck cancer	7.03e-05	0.00082	CcSEcCtD
Doxorubicin—Weight decreased—Docetaxel—head and neck cancer	6.99e-05	0.000816	CcSEcCtD
Doxorubicin—Feeling abnormal—Hydroxyurea—head and neck cancer	6.97e-05	0.000813	CcSEcCtD
Doxorubicin—Pneumonia—Docetaxel—head and neck cancer	6.93e-05	0.000808	CcSEcCtD
Doxorubicin—Anaemia—Fluorouracil—head and neck cancer	6.89e-05	0.000804	CcSEcCtD
Doxorubicin—Infestation NOS—Docetaxel—head and neck cancer	6.89e-05	0.000804	CcSEcCtD
Doxorubicin—Infestation—Docetaxel—head and neck cancer	6.89e-05	0.000804	CcSEcCtD
Doxorubicin—Hypersensitivity—Vinblastine—head and neck cancer	6.83e-05	0.000797	CcSEcCtD
Doxorubicin—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	6.83e-05	0.000797	CcSEcCtD
Doxorubicin—Renal failure—Docetaxel—head and neck cancer	6.77e-05	0.00079	CcSEcCtD
Doxorubicin—Neuropathy peripheral—Docetaxel—head and neck cancer	6.75e-05	0.000788	CcSEcCtD
Doxorubicin—Stomatitis—Docetaxel—head and neck cancer	6.72e-05	0.000783	CcSEcCtD
Doxorubicin—Jaundice—Docetaxel—head and neck cancer	6.72e-05	0.000783	CcSEcCtD
Doxorubicin—Conjunctivitis—Docetaxel—head and neck cancer	6.7e-05	0.000781	CcSEcCtD
Doxorubicin—Body temperature increased—Hydroxyurea—head and neck cancer	6.69e-05	0.00078	CcSEcCtD
Doxorubicin—Leukopenia—Fluorouracil—head and neck cancer	6.68e-05	0.000779	CcSEcCtD
Doxorubicin—Asthenia—Vinblastine—head and neck cancer	6.65e-05	0.000776	CcSEcCtD
Doxorubicin—ABCC2—lymph node—head and neck cancer	6.55e-05	0.00156	CbGeAlD
Doxorubicin—Hepatobiliary disease—Docetaxel—head and neck cancer	6.52e-05	0.00076	CcSEcCtD
Doxorubicin—Epistaxis—Docetaxel—head and neck cancer	6.5e-05	0.000758	CcSEcCtD
Doxorubicin—Convulsion—Fluorouracil—head and neck cancer	6.46e-05	0.000754	CcSEcCtD
Doxorubicin—Agranulocytosis—Docetaxel—head and neck cancer	6.43e-05	0.00075	CcSEcCtD
Doxorubicin—CYP1B1—lymph node—head and neck cancer	6.41e-05	0.00152	CbGeAlD
Doxorubicin—Myalgia—Fluorouracil—head and neck cancer	6.35e-05	0.000741	CcSEcCtD
Doxorubicin—Chest pain—Fluorouracil—head and neck cancer	6.35e-05	0.000741	CcSEcCtD
Doxorubicin—Diarrhoea—Vinblastine—head and neck cancer	6.35e-05	0.00074	CcSEcCtD
Doxorubicin—CYP2B6—head—head and neck cancer	6.29e-05	0.00149	CbGeAlD
Doxorubicin—Discomfort—Fluorouracil—head and neck cancer	6.27e-05	0.000732	CcSEcCtD
Doxorubicin—Hypersensitivity—Hydroxyurea—head and neck cancer	6.23e-05	0.000727	CcSEcCtD
Doxorubicin—Haemoglobin—Docetaxel—head and neck cancer	6.22e-05	0.000725	CcSEcCtD
Doxorubicin—Rhinitis—Docetaxel—head and neck cancer	6.2e-05	0.000723	CcSEcCtD
Doxorubicin—Hepatitis—Docetaxel—head and neck cancer	6.18e-05	0.000722	CcSEcCtD
Doxorubicin—Haemorrhage—Docetaxel—head and neck cancer	6.18e-05	0.000722	CcSEcCtD
Doxorubicin—Hypoaesthesia—Docetaxel—head and neck cancer	6.15e-05	0.000718	CcSEcCtD
Doxorubicin—Confusional state—Fluorouracil—head and neck cancer	6.14e-05	0.000716	CcSEcCtD
Doxorubicin—Pharyngitis—Docetaxel—head and neck cancer	6.14e-05	0.000716	CcSEcCtD
Doxorubicin—Dizziness—Vinblastine—head and neck cancer	6.13e-05	0.000715	CcSEcCtD
Doxorubicin—Urinary tract disorder—Docetaxel—head and neck cancer	6.11e-05	0.000713	CcSEcCtD
Doxorubicin—Oedema peripheral—Docetaxel—head and neck cancer	6.09e-05	0.000711	CcSEcCtD
Doxorubicin—Oedema—Fluorouracil—head and neck cancer	6.09e-05	0.00071	CcSEcCtD
Doxorubicin—Anaphylactic shock—Fluorouracil—head and neck cancer	6.09e-05	0.00071	CcSEcCtD
Doxorubicin—Connective tissue disorder—Docetaxel—head and neck cancer	6.08e-05	0.000709	CcSEcCtD
Doxorubicin—Asthenia—Hydroxyurea—head and neck cancer	6.07e-05	0.000708	CcSEcCtD
Doxorubicin—Urethral disorder—Docetaxel—head and neck cancer	6.06e-05	0.000707	CcSEcCtD
Doxorubicin—Infection—Fluorouracil—head and neck cancer	6.05e-05	0.000706	CcSEcCtD
Doxorubicin—Nervous system disorder—Fluorouracil—head and neck cancer	5.97e-05	0.000696	CcSEcCtD
Doxorubicin—Thrombocytopenia—Fluorouracil—head and neck cancer	5.96e-05	0.000695	CcSEcCtD
Doxorubicin—Visual impairment—Docetaxel—head and neck cancer	5.96e-05	0.000695	CcSEcCtD
Doxorubicin—Tachycardia—Fluorouracil—head and neck cancer	5.94e-05	0.000693	CcSEcCtD
Doxorubicin—Vomiting—Vinblastine—head and neck cancer	5.9e-05	0.000688	CcSEcCtD
Doxorubicin—Erythema multiforme—Docetaxel—head and neck cancer	5.85e-05	0.000682	CcSEcCtD
Doxorubicin—Headache—Vinblastine—head and neck cancer	5.81e-05	0.000678	CcSEcCtD
Doxorubicin—Anorexia—Fluorouracil—head and neck cancer	5.8e-05	0.000677	CcSEcCtD
Doxorubicin—Diarrhoea—Hydroxyurea—head and neck cancer	5.79e-05	0.000675	CcSEcCtD
Doxorubicin—Eye disorder—Docetaxel—head and neck cancer	5.78e-05	0.000674	CcSEcCtD
Doxorubicin—ABCC1—lymph node—head and neck cancer	5.77e-05	0.00137	CbGeAlD
Doxorubicin—Cardiac disorder—Docetaxel—head and neck cancer	5.74e-05	0.00067	CcSEcCtD
Doxorubicin—Flushing—Docetaxel—head and neck cancer	5.74e-05	0.00067	CcSEcCtD
Doxorubicin—Hypotension—Fluorouracil—head and neck cancer	5.69e-05	0.000664	CcSEcCtD
Doxorubicin—Angiopathy—Docetaxel—head and neck cancer	5.61e-05	0.000655	CcSEcCtD
Doxorubicin—Dizziness—Hydroxyurea—head and neck cancer	5.59e-05	0.000652	CcSEcCtD
Doxorubicin—Immune system disorder—Docetaxel—head and neck cancer	5.59e-05	0.000652	CcSEcCtD
Doxorubicin—Mediastinal disorder—Docetaxel—head and neck cancer	5.57e-05	0.00065	CcSEcCtD
Doxorubicin—Chills—Docetaxel—head and neck cancer	5.55e-05	0.000647	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	5.55e-05	0.000647	CcSEcCtD
Doxorubicin—Arrhythmia—Docetaxel—head and neck cancer	5.52e-05	0.000645	CcSEcCtD
Doxorubicin—Nausea—Vinblastine—head and neck cancer	5.51e-05	0.000643	CcSEcCtD
Doxorubicin—Insomnia—Fluorouracil—head and neck cancer	5.51e-05	0.000642	CcSEcCtD
Doxorubicin—Paraesthesia—Fluorouracil—head and neck cancer	5.47e-05	0.000638	CcSEcCtD
Doxorubicin—Alopecia—Docetaxel—head and neck cancer	5.46e-05	0.000638	CcSEcCtD
Doxorubicin—Dyspnoea—Fluorouracil—head and neck cancer	5.43e-05	0.000633	CcSEcCtD
Doxorubicin—Mental disorder—Docetaxel—head and neck cancer	5.42e-05	0.000632	CcSEcCtD
Doxorubicin—ABCB1—epithelium—head and neck cancer	5.42e-05	0.00129	CbGeAlD
Doxorubicin—Somnolence—Fluorouracil—head and neck cancer	5.41e-05	0.000631	CcSEcCtD
Doxorubicin—Malnutrition—Docetaxel—head and neck cancer	5.38e-05	0.000628	CcSEcCtD
Doxorubicin—Erythema—Docetaxel—head and neck cancer	5.38e-05	0.000628	CcSEcCtD
Doxorubicin—Vomiting—Hydroxyurea—head and neck cancer	5.38e-05	0.000627	CcSEcCtD
Doxorubicin—Dyspepsia—Fluorouracil—head and neck cancer	5.36e-05	0.000625	CcSEcCtD
Doxorubicin—Rash—Hydroxyurea—head and neck cancer	5.33e-05	0.000622	CcSEcCtD
Doxorubicin—Dermatitis—Hydroxyurea—head and neck cancer	5.33e-05	0.000622	CcSEcCtD
Doxorubicin—Headache—Hydroxyurea—head and neck cancer	5.3e-05	0.000618	CcSEcCtD
Doxorubicin—Decreased appetite—Fluorouracil—head and neck cancer	5.29e-05	0.000617	CcSEcCtD
Doxorubicin—Dysgeusia—Docetaxel—head and neck cancer	5.27e-05	0.000615	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Fluorouracil—head and neck cancer	5.26e-05	0.000613	CcSEcCtD
Doxorubicin—Back pain—Docetaxel—head and neck cancer	5.21e-05	0.000608	CcSEcCtD
Doxorubicin—Pain—Fluorouracil—head and neck cancer	5.21e-05	0.000607	CcSEcCtD
Doxorubicin—Muscle spasms—Docetaxel—head and neck cancer	5.18e-05	0.000604	CcSEcCtD
Doxorubicin—Nausea—Hydroxyurea—head and neck cancer	5.02e-05	0.000586	CcSEcCtD
Doxorubicin—Feeling abnormal—Fluorouracil—head and neck cancer	5.02e-05	0.000585	CcSEcCtD
Doxorubicin—Anaemia—Docetaxel—head and neck cancer	4.98e-05	0.000581	CcSEcCtD
Doxorubicin—Urticaria—Fluorouracil—head and neck cancer	4.84e-05	0.000564	CcSEcCtD
Doxorubicin—Syncope—Docetaxel—head and neck cancer	4.83e-05	0.000563	CcSEcCtD
Doxorubicin—Leukopenia—Docetaxel—head and neck cancer	4.82e-05	0.000562	CcSEcCtD
Doxorubicin—Body temperature increased—Fluorouracil—head and neck cancer	4.81e-05	0.000561	CcSEcCtD
Doxorubicin—ABCB1—trachea—head and neck cancer	4.79e-05	0.00114	CbGeAlD
Doxorubicin—ABCG2—lymph node—head and neck cancer	4.77e-05	0.00113	CbGeAlD
Doxorubicin—Palpitations—Docetaxel—head and neck cancer	4.76e-05	0.000555	CcSEcCtD
Doxorubicin—Loss of consciousness—Docetaxel—head and neck cancer	4.73e-05	0.000552	CcSEcCtD
Doxorubicin—Cough—Docetaxel—head and neck cancer	4.7e-05	0.000548	CcSEcCtD
Doxorubicin—CYP2D6—head—head and neck cancer	4.67e-05	0.00111	CbGeAlD
Doxorubicin—Convulsion—Docetaxel—head and neck cancer	4.66e-05	0.000544	CcSEcCtD
Doxorubicin—Hypertension—Docetaxel—head and neck cancer	4.65e-05	0.000542	CcSEcCtD
Doxorubicin—Arthralgia—Docetaxel—head and neck cancer	4.58e-05	0.000535	CcSEcCtD
Doxorubicin—Myalgia—Docetaxel—head and neck cancer	4.58e-05	0.000535	CcSEcCtD
Doxorubicin—Chest pain—Docetaxel—head and neck cancer	4.58e-05	0.000535	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	4.55e-05	0.000531	CcSEcCtD
Doxorubicin—Hypersensitivity—Fluorouracil—head and neck cancer	4.48e-05	0.000523	CcSEcCtD
Doxorubicin—Dry mouth—Docetaxel—head and neck cancer	4.48e-05	0.000523	CcSEcCtD
Doxorubicin—Confusional state—Docetaxel—head and neck cancer	4.43e-05	0.000517	CcSEcCtD
Doxorubicin—Anaphylactic shock—Docetaxel—head and neck cancer	4.39e-05	0.000513	CcSEcCtD
Doxorubicin—Oedema—Docetaxel—head and neck cancer	4.39e-05	0.000513	CcSEcCtD
Doxorubicin—Infection—Docetaxel—head and neck cancer	4.36e-05	0.000509	CcSEcCtD
Doxorubicin—Shock—Docetaxel—head and neck cancer	4.32e-05	0.000504	CcSEcCtD
Doxorubicin—Nervous system disorder—Docetaxel—head and neck cancer	4.31e-05	0.000503	CcSEcCtD
Doxorubicin—Pruritus—Fluorouracil—head and neck cancer	4.31e-05	0.000502	CcSEcCtD
Doxorubicin—Thrombocytopenia—Docetaxel—head and neck cancer	4.3e-05	0.000502	CcSEcCtD
Doxorubicin—Tachycardia—Docetaxel—head and neck cancer	4.29e-05	0.0005	CcSEcCtD
Doxorubicin—Skin disorder—Docetaxel—head and neck cancer	4.27e-05	0.000498	CcSEcCtD
Doxorubicin—Anorexia—Docetaxel—head and neck cancer	4.19e-05	0.000489	CcSEcCtD
Doxorubicin—ABCB1—lymphoid tissue—head and neck cancer	4.17e-05	0.000991	CbGeAlD
Doxorubicin—Diarrhoea—Fluorouracil—head and neck cancer	4.17e-05	0.000486	CcSEcCtD
Doxorubicin—Hypotension—Docetaxel—head and neck cancer	4.11e-05	0.000479	CcSEcCtD
Doxorubicin—Dizziness—Fluorouracil—head and neck cancer	4.03e-05	0.00047	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Docetaxel—head and neck cancer	4e-05	0.000467	CcSEcCtD
Doxorubicin—Insomnia—Docetaxel—head and neck cancer	3.97e-05	0.000464	CcSEcCtD
Doxorubicin—Paraesthesia—Docetaxel—head and neck cancer	3.95e-05	0.00046	CcSEcCtD
Doxorubicin—Dyspnoea—Docetaxel—head and neck cancer	3.92e-05	0.000457	CcSEcCtD
Doxorubicin—Somnolence—Docetaxel—head and neck cancer	3.91e-05	0.000456	CcSEcCtD
Doxorubicin—Vomiting—Fluorouracil—head and neck cancer	3.87e-05	0.000452	CcSEcCtD
Doxorubicin—Dyspepsia—Docetaxel—head and neck cancer	3.87e-05	0.000451	CcSEcCtD
Doxorubicin—Rash—Fluorouracil—head and neck cancer	3.84e-05	0.000448	CcSEcCtD
Doxorubicin—Dermatitis—Fluorouracil—head and neck cancer	3.83e-05	0.000447	CcSEcCtD
Doxorubicin—Decreased appetite—Docetaxel—head and neck cancer	3.82e-05	0.000446	CcSEcCtD
Doxorubicin—Headache—Fluorouracil—head and neck cancer	3.81e-05	0.000445	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Docetaxel—head and neck cancer	3.79e-05	0.000443	CcSEcCtD
Doxorubicin—ABCB1—thyroid gland—head and neck cancer	3.79e-05	0.0009	CbGeAlD
Doxorubicin—Fatigue—Docetaxel—head and neck cancer	3.79e-05	0.000442	CcSEcCtD
Doxorubicin—Pain—Docetaxel—head and neck cancer	3.76e-05	0.000438	CcSEcCtD
Doxorubicin—Constipation—Docetaxel—head and neck cancer	3.76e-05	0.000438	CcSEcCtD
Doxorubicin—Feeling abnormal—Docetaxel—head and neck cancer	3.62e-05	0.000422	CcSEcCtD
Doxorubicin—Nausea—Fluorouracil—head and neck cancer	3.62e-05	0.000422	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Docetaxel—head and neck cancer	3.59e-05	0.000419	CcSEcCtD
Doxorubicin—Body temperature increased—Docetaxel—head and neck cancer	3.47e-05	0.000405	CcSEcCtD
Doxorubicin—Abdominal pain—Docetaxel—head and neck cancer	3.47e-05	0.000405	CcSEcCtD
Doxorubicin—ABCB1—head—head and neck cancer	3.36e-05	0.000799	CbGeAlD
Doxorubicin—Hypersensitivity—Docetaxel—head and neck cancer	3.24e-05	0.000378	CcSEcCtD
Doxorubicin—Asthenia—Docetaxel—head and neck cancer	3.15e-05	0.000368	CcSEcCtD
Doxorubicin—Pruritus—Docetaxel—head and neck cancer	3.11e-05	0.000363	CcSEcCtD
Doxorubicin—Diarrhoea—Docetaxel—head and neck cancer	3.01e-05	0.000351	CcSEcCtD
Doxorubicin—Dizziness—Docetaxel—head and neck cancer	2.91e-05	0.000339	CcSEcCtD
Doxorubicin—Vomiting—Docetaxel—head and neck cancer	2.79e-05	0.000326	CcSEcCtD
Doxorubicin—Rash—Docetaxel—head and neck cancer	2.77e-05	0.000323	CcSEcCtD
Doxorubicin—Dermatitis—Docetaxel—head and neck cancer	2.77e-05	0.000323	CcSEcCtD
Doxorubicin—Headache—Docetaxel—head and neck cancer	2.75e-05	0.000321	CcSEcCtD
Doxorubicin—Nausea—Docetaxel—head and neck cancer	2.61e-05	0.000304	CcSEcCtD
Doxorubicin—ABCB1—lymph node—head and neck cancer	2.35e-05	0.000559	CbGeAlD
Doxorubicin—CYP1B1—Metabolism—DPYD—head and neck cancer	9.72e-06	0.000178	CbGpPWpGaD
Doxorubicin—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	9.7e-06	0.000178	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—CCND1—head and neck cancer	9.69e-06	0.000178	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—CYP1A1—head and neck cancer	9.69e-06	0.000178	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—MAPK3—head and neck cancer	9.62e-06	0.000176	CbGpPWpGaD
Doxorubicin—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	9.6e-06	0.000176	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—PTEN—head and neck cancer	9.59e-06	0.000176	CbGpPWpGaD
Doxorubicin—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	9.57e-06	0.000175	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	9.54e-06	0.000175	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—YAP1—head and neck cancer	9.53e-06	0.000175	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—HRAS—head and neck cancer	9.47e-06	0.000174	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—TYMS—head and neck cancer	9.4e-06	0.000172	CbGpPWpGaD
Doxorubicin—NOS1—Disease—PTEN—head and neck cancer	9.31e-06	0.000171	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—GSTM1—head and neck cancer	9.29e-06	0.00017	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—YAP1—head and neck cancer	9.22e-06	0.000169	CbGpPWpGaD
Doxorubicin—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	9.19e-06	0.000169	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—MAPK1—head and neck cancer	9.16e-06	0.000168	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	9.14e-06	0.000168	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—TP53—head and neck cancer	9.13e-06	0.000167	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—PIK3CA—head and neck cancer	9.08e-06	0.000166	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—PIK3CA—head and neck cancer	9.08e-06	0.000166	CbGpPWpGaD
Doxorubicin—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	9.07e-06	0.000166	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—MAPK3—head and neck cancer	8.94e-06	0.000164	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—GPX1—head and neck cancer	8.89e-06	0.000163	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—DPYD—head and neck cancer	8.84e-06	0.000162	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—CYP1A1—head and neck cancer	8.8e-06	0.000161	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—IL2—head and neck cancer	8.67e-06	0.000159	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	8.59e-06	0.000157	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	8.56e-06	0.000157	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—PIK3CA—head and neck cancer	8.54e-06	0.000156	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—MAPK1—head and neck cancer	8.51e-06	0.000156	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CCND1—head and neck cancer	8.45e-06	0.000155	CbGpPWpGaD
Doxorubicin—NOS3—Disease—NOTCH1—head and neck cancer	8.42e-06	0.000154	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—YAP1—head and neck cancer	8.39e-06	0.000154	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—AKT1—head and neck cancer	8.36e-06	0.000153	CbGpPWpGaD
Doxorubicin—NOS1—Disease—STAT3—head and neck cancer	8.33e-06	0.000153	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	8.32e-06	0.000152	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	8.16e-06	0.00015	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—PTEN—head and neck cancer	8.15e-06	0.000149	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—UROD—head and neck cancer	8.09e-06	0.000148	CbGpPWpGaD
Doxorubicin—NOS2—Disease—PTGS2—head and neck cancer	8.05e-06	0.000148	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—MAPK3—head and neck cancer	7.99e-06	0.000147	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	7.97e-06	0.000146	CbGpPWpGaD
Doxorubicin—NOS1—Disease—MAPK3—head and neck cancer	7.95e-06	0.000146	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—PIK3CA—head and neck cancer	7.94e-06	0.000146	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—TP53—head and neck cancer	7.69e-06	0.000141	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—TYMS—head and neck cancer	7.62e-06	0.00014	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—MAPK1—head and neck cancer	7.61e-06	0.000139	CbGpPWpGaD
Doxorubicin—NOS1—Disease—MAPK1—head and neck cancer	7.57e-06	0.000139	CbGpPWpGaD
Doxorubicin—NOS1—Disease—EGFR—head and neck cancer	7.57e-06	0.000139	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—GSTM1—head and neck cancer	7.53e-06	0.000138	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—AKT1—head and neck cancer	7.42e-06	0.000136	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—AKT1—head and neck cancer	7.42e-06	0.000136	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—PTGS2—head and neck cancer	7.4e-06	0.000136	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—NAT2—head and neck cancer	7.39e-06	0.000135	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	7.37e-06	0.000135	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—VEGFA—head and neck cancer	7.37e-06	0.000135	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—HRAS—head and neck cancer	7.35e-06	0.000135	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—TYMS—head and neck cancer	7.31e-06	0.000134	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—STAT3—head and neck cancer	7.29e-06	0.000134	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—PIK3CA—head and neck cancer	7.26e-06	0.000133	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—GSTM1—head and neck cancer	7.22e-06	0.000132	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—GPX1—head and neck cancer	7.21e-06	0.000132	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	7.16e-06	0.000131	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—CYP1A1—head and neck cancer	7.14e-06	0.000131	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	7.12e-06	0.00013	CbGpPWpGaD
Doxorubicin—NOS2—Disease—PTEN—head and neck cancer	7.02e-06	0.000129	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—NOTCH1—head and neck cancer	6.98e-06	0.000128	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—AKT1—head and neck cancer	6.97e-06	0.000128	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—MAPK3—head and neck cancer	6.97e-06	0.000128	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	6.93e-06	0.000127	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—GPX1—head and neck cancer	6.92e-06	0.000127	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—CYP1A1—head and neck cancer	6.85e-06	0.000126	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—PIK3CA—head and neck cancer	6.77e-06	0.000124	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—MAPK1—head and neck cancer	6.63e-06	0.000122	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—EGFR—head and neck cancer	6.63e-06	0.000121	CbGpPWpGaD
Doxorubicin—NOS1—Disease—PIK3CA—head and neck cancer	6.57e-06	0.00012	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—AKT1—head and neck cancer	6.49e-06	0.000119	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—DPYD—head and neck cancer	6.48e-06	0.000119	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—PTEN—head and neck cancer	6.45e-06	0.000118	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	6.43e-06	0.000118	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—PTGS2—head and neck cancer	6.42e-06	0.000118	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—TP53—head and neck cancer	6.39e-06	0.000117	CbGpPWpGaD
Doxorubicin—NOS2—Disease—STAT3—head and neck cancer	6.28e-06	0.000115	CbGpPWpGaD
Doxorubicin—NOS3—Disease—PTGS2—head and neck cancer	6.25e-06	0.000115	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	6.25e-06	0.000115	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PTGS2—head and neck cancer	6.2e-06	0.000114	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—YAP1—head and neck cancer	6.15e-06	0.000113	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	6.08e-06	0.000111	CbGpPWpGaD
Doxorubicin—NOS1—Disease—HRAS—head and neck cancer	6.08e-06	0.000111	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	6.04e-06	0.000111	CbGpPWpGaD
Doxorubicin—NOS2—Disease—MAPK3—head and neck cancer	6e-06	0.00011	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—AKT1—head and neck cancer	5.93e-06	0.000109	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—NOTCH1—head and neck cancer	5.9e-06	0.000108	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.87e-06	0.000108	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	5.79e-06	0.000106	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	5.79e-06	0.000106	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—STAT3—head and neck cancer	5.77e-06	0.000106	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PTGS2—head and neck cancer	5.76e-06	0.000106	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—PIK3CA—head and neck cancer	5.75e-06	0.000105	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—TYMS—head and neck cancer	5.73e-06	0.000105	CbGpPWpGaD
Doxorubicin—NOS2—Disease—MAPK1—head and neck cancer	5.71e-06	0.000105	CbGpPWpGaD
Doxorubicin—NOS2—Disease—EGFR—head and neck cancer	5.71e-06	0.000105	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—GSTM1—head and neck cancer	5.66e-06	0.000104	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.62e-06	0.000103	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—PTEN—head and neck cancer	5.6e-06	0.000103	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TP53—head and neck cancer	5.57e-06	0.000102	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—TYMS—head and neck cancer	5.54e-06	0.000101	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—AKT1—head and neck cancer	5.53e-06	0.000101	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—MAPK3—head and neck cancer	5.51e-06	0.000101	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—GSTM1—head and neck cancer	5.47e-06	0.0001	CbGpPWpGaD
Doxorubicin—NOS3—Disease—PTEN—head and neck cancer	5.45e-06	9.99e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—NAT2—head and neck cancer	5.45e-06	9.99e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—GPX1—head and neck cancer	5.42e-06	9.93e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PTEN—head and neck cancer	5.4e-06	9.91e-05	CbGpPWpGaD
Doxorubicin—NOS1—Disease—AKT1—head and neck cancer	5.36e-06	9.83e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—CYP1A1—head and neck cancer	5.36e-06	9.83e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—HRAS—head and neck cancer	5.32e-06	9.76e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—MAPK1—head and neck cancer	5.25e-06	9.62e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—EGFR—head and neck cancer	5.24e-06	9.61e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—GPX1—head and neck cancer	5.24e-06	9.61e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PTGS2—head and neck cancer	5.24e-06	9.6e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—CYP1A1—head and neck cancer	5.19e-06	9.51e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—NAT2—head and neck cancer	5.14e-06	9.42e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—NOTCH1—head and neck cancer	5.13e-06	9.41e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—TYMS—head and neck cancer	5.04e-06	9.23e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PTEN—head and neck cancer	5.02e-06	9.21e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	5.02e-06	9.2e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GSTM1—head and neck cancer	4.98e-06	9.13e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—PIK3CA—head and neck cancer	4.95e-06	9.08e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—STAT3—head and neck cancer	4.88e-06	8.94e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	4.86e-06	8.9e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL2—head and neck cancer	4.8e-06	8.8e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—DPYD—head and neck cancer	4.78e-06	8.76e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GPX1—head and neck cancer	4.77e-06	8.74e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CYP1A1—head and neck cancer	4.72e-06	8.65e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—AKT1—head and neck cancer	4.7e-06	8.61e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CCND1—head and neck cancer	4.68e-06	8.58e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—MAPK3—head and neck cancer	4.66e-06	8.54e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—HRAS—head and neck cancer	4.58e-06	8.4e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PTEN—head and neck cancer	4.57e-06	8.37e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—PIK3CA—head and neck cancer	4.55e-06	8.34e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—YAP1—head and neck cancer	4.54e-06	8.31e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PTEN—head and neck cancer	4.52e-06	8.28e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—DPYD—head and neck cancer	4.5e-06	8.26e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—MAPK1—head and neck cancer	4.43e-06	8.12e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—EGFR—head and neck cancer	4.43e-06	8.12e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.41e-06	8.08e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—YAP1—head and neck cancer	4.27e-06	7.83e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.26e-06	7.81e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PTGS2—head and neck cancer	4.25e-06	7.78e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—HRAS—head and neck cancer	4.21e-06	7.72e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	4.1e-06	7.52e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—VEGFA—head and neck cancer	4.08e-06	7.48e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PTGS2—head and neck cancer	4.07e-06	7.46e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL2—head and neck cancer	4.06e-06	7.44e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—AKT1—head and neck cancer	4.05e-06	7.42e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—STAT3—head and neck cancer	4.04e-06	7.41e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCND1—head and neck cancer	3.96e-06	7.25e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—PIK3CA—head and neck cancer	3.95e-06	7.24e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MAPK3—head and neck cancer	3.86e-06	7.08e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—PIK3CA—head and neck cancer	3.85e-06	7.05e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PTEN—head and neck cancer	3.82e-06	7e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PIK3CA—head and neck cancer	3.81e-06	6.99e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PTGS2—head and neck cancer	3.81e-06	6.98e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—AKT1—head and neck cancer	3.72e-06	6.82e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PTEN—head and neck cancer	3.7e-06	6.79e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—TYMS—head and neck cancer	3.69e-06	6.77e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MAPK1—head and neck cancer	3.67e-06	6.73e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—EGFR—head and neck cancer	3.67e-06	6.73e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GSTM1—head and neck cancer	3.65e-06	6.69e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—HRAS—head and neck cancer	3.56e-06	6.52e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PTEN—head and neck cancer	3.55e-06	6.51e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PIK3CA—head and neck cancer	3.54e-06	6.5e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GPX1—head and neck cancer	3.5e-06	6.41e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CYP1A1—head and neck cancer	3.46e-06	6.34e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—VEGFA—head and neck cancer	3.45e-06	6.32e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—STAT3—head and neck cancer	3.41e-06	6.26e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NAT2—head and neck cancer	3.36e-06	6.16e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PTEN—head and neck cancer	3.32e-06	6.09e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MAPK3—head and neck cancer	3.26e-06	5.98e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—AKT1—head and neck cancer	3.23e-06	5.92e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PIK3CA—head and neck cancer	3.22e-06	5.9e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PTGS2—head and neck cancer	3.19e-06	5.85e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PIK3CA—head and neck cancer	3.19e-06	5.84e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—AKT1—head and neck cancer	3.14e-06	5.76e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—AKT1—head and neck cancer	3.11e-06	5.71e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MAPK1—head and neck cancer	3.1e-06	5.69e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—EGFR—head and neck cancer	3.1e-06	5.69e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PTGS2—head and neck cancer	3.09e-06	5.66e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TP53—head and neck cancer	3.08e-06	5.65e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—STAT3—head and neck cancer	2.97e-06	5.45e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—HRAS—head and neck cancer	2.95e-06	5.41e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—DPYD—head and neck cancer	2.94e-06	5.4e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—AKT1—head and neck cancer	2.9e-06	5.31e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MAPK3—head and neck cancer	2.84e-06	5.2e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PTGS2—head and neck cancer	2.81e-06	5.15e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—YAP1—head and neck cancer	2.79e-06	5.12e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PTEN—head and neck cancer	2.78e-06	5.1e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—TYMS—head and neck cancer	2.72e-06	4.99e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MAPK1—head and neck cancer	2.7e-06	4.95e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—EGFR—head and neck cancer	2.7e-06	4.95e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PIK3CA—head and neck cancer	2.69e-06	4.94e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GSTM1—head and neck cancer	2.69e-06	4.93e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PTEN—head and neck cancer	2.69e-06	4.93e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—AKT1—head and neck cancer	2.63e-06	4.82e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PIK3CA—head and neck cancer	2.61e-06	4.79e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TP53—head and neck cancer	2.61e-06	4.78e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—AKT1—head and neck cancer	2.6e-06	4.77e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GPX1—head and neck cancer	2.58e-06	4.73e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—TYMS—head and neck cancer	2.57e-06	4.7e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CYP1A1—head and neck cancer	2.55e-06	4.68e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GSTM1—head and neck cancer	2.54e-06	4.65e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PIK3CA—head and neck cancer	2.51e-06	4.59e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—HRAS—head and neck cancer	2.49e-06	4.57e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PTEN—head and neck cancer	2.45e-06	4.49e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GPX1—head and neck cancer	2.43e-06	4.45e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CYP1A1—head and neck cancer	2.41e-06	4.41e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PIK3CA—head and neck cancer	2.34e-06	4.3e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—AKT1—head and neck cancer	2.2e-06	4.03e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—HRAS—head and neck cancer	2.17e-06	3.97e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—AKT1—head and neck cancer	2.13e-06	3.91e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PTGS2—head and neck cancer	2.06e-06	3.77e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—AKT1—head and neck cancer	2.05e-06	3.75e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PIK3CA—head and neck cancer	1.96e-06	3.6e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—AKT1—head and neck cancer	1.91e-06	3.51e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PIK3CA—head and neck cancer	1.9e-06	3.48e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PTEN—head and neck cancer	1.79e-06	3.29e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PIK3CA—head and neck cancer	1.73e-06	3.17e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—TYMS—head and neck cancer	1.68e-06	3.08e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.66e-06	3.04e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—AKT1—head and neck cancer	1.6e-06	2.94e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GPX1—head and neck cancer	1.59e-06	2.91e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.57e-06	2.88e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—AKT1—head and neck cancer	1.55e-06	2.84e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PTGS2—head and neck cancer	1.52e-06	2.78e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PTGS2—head and neck cancer	1.43e-06	2.62e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—AKT1—head and neck cancer	1.41e-06	2.59e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PTEN—head and neck cancer	1.32e-06	2.43e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PIK3CA—head and neck cancer	1.27e-06	2.32e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PTEN—head and neck cancer	1.25e-06	2.29e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—AKT1—head and neck cancer	1.03e-06	1.9e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PTGS2—head and neck cancer	9.35e-07	1.71e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PIK3CA—head and neck cancer	9.34e-07	1.71e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PIK3CA—head and neck cancer	8.8e-07	1.61e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PTEN—head and neck cancer	8.16e-07	1.49e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—AKT1—head and neck cancer	7.63e-07	1.4e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—AKT1—head and neck cancer	7.19e-07	1.32e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PIK3CA—head and neck cancer	5.75e-07	1.05e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—AKT1—head and neck cancer	4.7e-07	8.61e-06	CbGpPWpGaD
